Machine Learning

Zinnia's AI platform is modernizing Royal Neighbors' annuity processing, promising faster service and a new era of efficiency for a complex industry.

This strategic acquisition combines AI-driven tech with deep clinical expertise to help hospitals fight rising claim denials and severe margin pressure.

Publishers embrace EdTech as Wiley's content meets Top Hat's AI, promising a future of personalized, data-driven education for millions of students.

Sweden secures sovereign satellite capabilities in a 9-figure deal, signaling a new era of European defense autonomy and disrupting the space industry.

Following a $25M fundraise, former WA Health Secretary Dr. Shah joins Jaan Health, signaling a new era for AI-driven chronic disease management.

Biotech veteran Kamran Tavangar, who built a multi-billion dollar company at LabCentral, returns to lead its science strategy and shape the future of innovation.

The AI security firm regained reporting compliance, but a critical hearing and debt talks will decide its fate as it battles to stay on the exchange.

A new, AI-powered platform from Trust & Will offers free tools to solo attorneys, aiming to shift estate planning from a one-off task to a proactive relationship.

The strategic merger creates an end-to-end system connecting employee voice to business performance, challenging the competitive HR tech landscape.

Applied Brain Research secures seed funding to commercialize its TSP1 chip, promising private, real-time voice AI without the cloud for countless devices.

Manas AI gains unique access to Schrödinger's physics platform, uniting top minds and tech to slash drug development timelines. Is this the future?

With $6.5M CAD in new funding, Montréal's AI4Eyes is set to accelerate the global launch of its all-in-one diagnostic and treatment platform.

How did ZAGG dominate the phone case market? A deep dive into the strategy blending rugged protection, eco-friendly design, and retail power.

As McGraw Hill execs prep for a key investor conference, all eyes are on their digital-first strategy and how they'll navigate the AI-driven EdTech boom.

NYU Langone and tech firm Tempus are launching a new protocol using serial DNA sequencing and AI to create hyper-personalized cancer treatments.

ConcertAI and Foundation Medicine unite to create a huge dataset of 500k patients, using AI to accelerate the hunt for new life-saving cancer drugs.

Cogent Biosciences is set for a transformative year, eyeing three FDA submissions and a launch for its lead drug, with a deep pipeline to follow.

A major new partnership is racing to deploy predictive tech, from blood tests to eye scans, to prevent millions of stillbirths in years, not decades.

FDA clears a novel two-part immunotherapy that paints solid tumors with a synthetic target, unleashing a powerful CAR T-cell attack in a new clinical trial.

Promising new 96-week data shows Vir's therapy could redefine care for severe hepatitis delta, as its oncology pipeline and financial runway also advance.